TERNS PHARMACEUTICALS INC. - COMMON STOCK

Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference

04 1 2024 16:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

03 1 2024 16:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit

29 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer

27 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Updates

14 11 2023 08:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023

13 11 2023 08:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences

09 11 2023 08:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

03 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral GLP-1 Receptor Agonist for Treatment of Obesity

02 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in Upcoming Investor Conferences

19 10 2023 16:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Announces Global Phase 1 Clinical Trial Design of TERN-701 for the Treatment of Chronic Myeloid Leukemia

16 10 2023 08:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

03 10 2023 16:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

06 9 2023 16:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in Upcoming September Investor Conferences

05 9 2023 16:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Updates

08 8 2023 16:15:00 提供 Nasdaq GlobeNewswire

Terns Achieves Primary Endpoint and All Secondary Endpoints in Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH

08 8 2023 16:05:02 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

03 8 2023 18:00:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Announces Leadership Transition

03 8 2023 17:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Host Virtual Key Opinion Leader Event to Discuss TERN-701 and Advances in the Treatment Landscape for Chronic Myeloid Leukemia

18 7 2023 16:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

05 7 2023 16:05:00 提供 Nasdaq GlobeNewswire